Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125267531 | 12526753 | 1 | I | 20160621 | 20160705 | 20160705 | EXP | CZ-ACTAVIS-2016-14587 | WATSON | 24.00 | YR | M | Y | 0.00000 | 20160705 | CN | CZ | CZ |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125267531 | 12526753 | 1 | PS | Risperidone (Unknown) | RISPERIDONE | 1 | Unknown | UNK | Y | UNCONFIRMED | 77860 | UNK | |||||||
| 125267531 | 12526753 | 2 | SS | Olanzapine (Unknown) | OLANZAPINE | 1 | Unknown | 20 MG, QPM | UNCONFIRMED | 0 | 20 | MG | UNK | QD | |||||
| 125267531 | 12526753 | 3 | SS | Olanzapine (Unknown) | OLANZAPINE | 1 | Oral | UNK | UNCONFIRMED | 0 | UNK | ||||||||
| 125267531 | 12526753 | 4 | SS | Olanzapine (Unknown) | OLANZAPINE | 1 | Intramuscular | UNK | UNCONFIRMED | 0 | UNK | ||||||||
| 125267531 | 12526753 | 5 | SS | Olanzapine (Unknown) | OLANZAPINE | 1 | Oral | 5 UNK, UNK | UNCONFIRMED | 0 | 5 | MG | UNK | QD | |||||
| 125267531 | 12526753 | 6 | SS | Mirtazapine (Unknown) | MIRTAZAPINE | 1 | Unknown | 45 MG, QPM | UNCONFIRMED | 0 | 45 | MG | UNK | QD | |||||
| 125267531 | 12526753 | 7 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG, QAM | U | UNCONFIRMED | 0 | 20 | MG | UNK | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125267531 | 12526753 | 1 | Schizophrenia |
| 125267531 | 12526753 | 2 | Schizophrenia |
| 125267531 | 12526753 | 6 | Schizophrenia |
| 125267531 | 12526753 | 7 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125267531 | 12526753 | HO |
| 125267531 | 12526753 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125267531 | 12526753 | Apathy | |
| 125267531 | 12526753 | Blunted affect | |
| 125267531 | 12526753 | Bradyphrenia | |
| 125267531 | 12526753 | Extrapyramidal disorder | |
| 125267531 | 12526753 | Fatigue | |
| 125267531 | 12526753 | Laziness | |
| 125267531 | 12526753 | Suicide attempt | |
| 125267531 | 12526753 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125267531 | 12526753 | 4 | 2014 | 0 | ||
| 125267531 | 12526753 | 5 | 201505 | 0 |